Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader. | Oncogene | 2023 | 36747009 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Regulation of the Innate Immune Response to Gout. | Immunol Invest | 2023 | 36745138 | PubTator, text mining | PubMed |
| Barriers to Treg therapy in Europe: From production to regulation. | Front Med (Lausanne) | 2023 | 36744143 | PubTator, text mining | PubMed |
| Nucleic DHX9 cooperates with STAT1 to transcribe interferon-stimulated genes. | Sci Adv | 2023 | 36735791 | PubTator, text mining | PubMed |
| The Legacy of Infectious Disease Exposure on the Genomic Diversity of Indigenous Southern Mexicans. | Genome Biol Evol | 2023 | 36726304 | PubTator, text mining | PubMed |
C-Reactive Protein-to-Albumin Ratio (CAR) and C-Reactive Protein-to-Lymphocyte Ratio (CLR) are Valuable Inflammatory Biomarker Combination for the Accurate Prediction of Periprosthetic Joint Infection. | Infect Drug Resist | 2023 | 36721632 | PubTator, text mining | PubMed |
| The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms. | Hum Immunol | 2023 | 36707384 | PubTator, text mining | PubMed |
| High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. | PLoS One | 2023 | 36706086 | PubTator, text mining | PubMed |
| The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity. | Commun Biol | 2023 | 36702861 | PubTator, text mining | PubMed |
| Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers. | Int J Mol Sci | 2023 | 36674809 | PubTator, text mining | PubMed |
| Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction. | Pharmacol Rev | 2023 | 36669831 | PubTator, text mining | PubMed |
| The Interplay between RNA Editing Regulator ADAR1 and Immune Environment in Colorectal Cancer. | J Oncol | 2023 | 36660243 | PubTator, text mining | PubMed |
| Genetic lesions and targeted therapy in Hodgkin lymphoma. | Ther Adv Hematol | 2023 | 36654739 | PubTator, text mining | PubMed |
| Clustering by antigen-presenting genes reveals immune landscapes and predicts response to checkpoint immunotherapy. | Sci Rep | 2023 | 36653470 | PubTator, text mining | PubMed |
| Impact of epigenetic reprogramming on antitumor immune responses in glioma. | J Clin Invest | 2023 | 36647827 | PubTator, text mining | PubMed |
| Improved cytosine base editors generated from TadA variants. | Nat Biotechnol | 2023 | 36624149 | PubTator, text mining | PubMed |
| Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development. | Life Sci | 2023 | 36621539 | PubTator, text mining | PubMed |
| P-TEFb: The master regulator of transcription elongation. | Mol Cell | 2023 | 36599353 | PubTator, text mining | PubMed |
| Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective. | Cells Tissues Organs | 2023 | 36599319 | PubTator, text mining | PubMed |
| Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression. | Nat Biotechnol | 2023 | 36593395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=27